Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium
Authors:
- Martin KöbelMKMartin Köbel
- Steve E. KallogerSKSteve E. Kalloger
- Sandra LeeSLSandra Lee
- Máire A. DugganMDMáire A. Duggan
- Linda E. KelemenLKLinda E. Kelemen
- Leah PrenticeLPLeah Prentice
- Kimberly R. KalliKKKimberly R. Kalli
- Brooke L. FridleyBFBrooke L. Fridley
- Daniel W. VisscherDVDaniel W. Visscher
- Gary L. KeeneyGKGary L. Keeney
- Robert A. VierkantRVRobert A. Vierkant
- Julie M. CunninghamJCJulie M. Cunningham
- 1 October 2013
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 22 (10) , 1677-1686
Abstract
Background: Ovarian carcinoma is composed of five major histologic types, which associate with outcome and predict therapeutic response. Our aim was to evaluate histologic type assessments across the centers participating in the Ovarian Tumor Tissue Analysis (OTTA) consortium using an immunohistochemical (IHC) prediction model. Methods: Tissue microarrays (TMA) and clinical data were available for 524 pathologically confirmed ovarian carcinomas. Centralized IHC was conducted for ARID1A, CDKN2A, DKK1, HNF1B, MDM2, PGR, TP53, TFF3, VIM, and WT1, and three histologic type assessments were compared: the original pathologic type, an IHC-based calculated type (termed TB_COSPv2), and a WT1-assisted TMA core review. Results: The concordance between TB_COSPv2 type and original type was 73%. Applying WT1-assisted core review, the remaining 27% discordant cases subdivided into unclassifiable (6%), TB_COSPv2 error (6%), and original type error (15%). The largest discordant subgroup was classified as endometrioid carcinoma by original type and as high-grade serous carcinoma (HGSC) by TB_COSPv2. When TB_COSPv2 classification was used, the difference in overall survival of endometrioid carcinoma compared with HGSC became significant [RR 0.60; 95% confidence interval (CI), 0.37–0.93; P = 0.021], consistent with previous reports. In addition, 71 cases with unclear original type could be histologically classified by TB_COSPv2. Conclusions: Research cohorts, particularly those across different centers within consortia, show significant variability in original histologic type diagnosis. Our IHC-based reclassification produced more homogeneous types with respect to outcome than original type. Impact: Biomarker-based classification of ovarian carcinomas is feasible, improves comparability of results across research studies, and can reclassify cases which lack reliable original pathology. Cancer Epidemiol Biomarkers Prev; 22(10); 1677–86. ©2013 AACR.Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studiesThe Lancet Oncology, 2012
- Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and Risk of Ovarian CancerEpidemiology, 2012
- Assessment of Hepatocyte Growth Factor in Ovarian Cancer MortalityCancer Epidemiology, Biomarkers & Prevention, 2011
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigmHuman Pathology, 2011
- ARID1AMutations in Endometriosis-Associated Ovarian CarcinomasNew England Journal of Medicine, 2010
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 2010
- A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Nature Genetics, 2010
- Genetic Variation in TYMS in the One-Carbon Transfer Pathway Is Associated with Ovarian Carcinoma Types in the Ovarian Cancer Association ConsortiumCancer Epidemiology, Biomarkers & Prevention, 2010
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryAmerican Journal of Surgical Pathology, 2010
- A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2Nature Genetics, 2009